Group 1 - The core viewpoint is that the Foshan Market Supervision Administration has implemented a registration reporting system for the sale of key controlled drugs in retail pharmacies starting from August 1, aimed at enhancing monitoring during the epidemic prevention efforts [1] - The drugs that require real-name registration include 47 types, specifically targeting symptoms caused by Chikungunya fever, such as fever, rash, and joint pain [1] - The registration process involves customers scanning a QR code for real-name verification and providing personal information, including symptoms and recent mosquito bites [1] Group 2 - According to the latest report from the Guangdong Provincial Disease Control Bureau, there were 2,892 new local cases of Chikungunya fever reported in the province from July 27 to August 2, with the majority of cases (2,770) occurring in Foshan [3] - The epidemic's rapid rise in Guangdong has shown initial signs of being contained, with a downward trend in new cases reported during the week [3] - Despite the containment efforts, the risk of imported cases remains due to frequent international exchanges and the ongoing challenges posed by weather conditions that promote mosquito activity [3]